SAB Biotherapeutics, Inc. Warrant (NASDAQ: SABSW) last traded at $0.00920, up 4.55% on the session. The quote above updates while this page is open; the figures below are drawn from SAB Biotherapeutics, Inc. Warrant’s own filings and are restated only when a new one is published.
SAB Biotherapeutics, Inc. Warrant trades on NASDAQ under the ticker SABSW. Its market capitalisation is $837,074.586.
Valuation measures for SAB Biotherapeutics, Inc. Warrant, derived from the latest quote and its most recent SEC filing.
| Market cap | $837.1K |
|---|---|
| Enterprise value | $16.00M |
| Price / book | 0.00 |
Trailing-twelve-month figures tagged in SAB Biotherapeutics, Inc. Warrant's XBRL filings with the SEC.
| Revenue (TTM) | $0.00 |
|---|---|
| Net income (TTM) |
| -$12.78M |
| Return on equity | -5.95% |
|---|
| Cash | $8.27M |
|---|
Range and volume for SABSW over the past 52 weeks.
| 52-week high | $0.00990 |
|---|---|
| 52-week low | $0.00920 |
| Volume | 22.7K |
| Average volume | 22.7K |
| Previous close | $0.00880 |
Invest a chosen dollar amount in SAB Biotherapeutics, Inc. Warrant with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell SABSW.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.